Announcement on Obtaining the "Drug Registration Certificate"
Filed with SSE · · 3 pages · Chinese
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- Announcement on 3rd Release and Circulation of Restricted Shares Involved in "2021 Restricted Shares Incentive Plan"
- Announcement on Implementation of Providing Guarantees for Subsidiaries' Bank Credit Lines
- Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
- Announcement on Implementation of Dividend Distribution of 2023
- Announcement on Marketing Approval of Terbutaline Sulfate Nebuliser Solution
Later from Jianmin Pharmaceutical
- Announcement on Convening Semi-annual Performance Briefing 2024
- 2024 Semi-annual Report Full Text
- Announcement on the Second Unlocking of Restricted Stock Involved in the 2022 Restricted Stock Incentive Plan
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
- Announcement on Holding the Performance Briefing for Q3 2024
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical